MicroRNAs are single-stranded snippets that, not long ago, were given short shrift as genetic junk. Now that studies have shown they regulate genes involved in normal functioning as well as diseases such as cancer, everyone wants to know: What regulates microRNAs?

Scientists at Johns Hopkins were surprised to find an elegantly simple answer: touch.

In a new study, published in the Proceedings of the National Academy of Sciences, the researchers discovered that cell-to-cell contact revs up the manufacture of these small but mighty molecules.

Ever miss your daily cup of coffee and subsequently get a pounding headache? According to reports from consumers of coffee and other caffeinated products, caffeine withdrawal is often characterized by a headache, fatigue, feeling less alert, less energetic and experiencing difficulty concentrating.  Caffeine withdrawal is at its worst between 24 to 48 hours and lasts up to a week.

LITTLETON, Colorado, May 1 /PRNewswire/ --

CPI Card Group, a world leader in card manufacturing and related solutions, is pleased to have received two Elan awards and five finalist positions at the 2009 ICMA Annual EXPO. The awards recognize the latest advancements and achievements in card design throughout the industry.

The only award that recognizes card design innovation as well as technical achievement in the industry, the ICMA Elan Awards honor card manufacturers and vendors for their excellent card design and innovative products. Each entry was selected by a panel of judges in a blind competition. Entries were judged solely on the card's features and were not identified by company. Delegates attending the Expo selected the People's Choice Award winners.

In a recent study (that yielded some exceptionally interesting results), catalytic RNA molecules were used in order to advance the understanding of Darwinian evolution.  Researchers Dr. Sarah Voytek and Professor Gerald Joyce of the Scripps Research Kellogg School of Science and Technology, choose RNA molecules because they evolve rapidly and self-replicating RNA molecules are hypothesized to be the first organic “life forms” on earth.  With a trillion molecules in a test tube replicating every few minutes, such an approach permits evolution to occur over the course of just a few days.

Following the positive outcomes of shorter studies done on Multiple Sclerosis (MS) drug Betaseron(R), continued testing also yields compelling results.

Analysis from a 16 year follow up study examining long term effects of Betaseron(R) on MS patients showed that early and continued treatment with Betaseron were more likely to avoid negative clinical outcomes than MS patients on alternative treatment options.

LONDON, May 1 /PRNewswire/ -- Telnic Limited (http://www.telnic.org), the registry operator for the new communications-focused top level domain .tel, today announced that it had been shortlisted by InfoCommerce Group ( http://www.infocommercegroup.com) for its 2009 Model of Excellence Awards.

Russell Perkins, Founder of InfoCommerce Group, said: Telnic is making a play to become a central destination for business and personal contact information with an approach that literally embeds this content into the infrastructure of the Internet, creating an online directory that offers blazingly fast response and can be accessed without even using a web browser. This is an incredibly innovative and powerful idea with huge potential.

 Everyone is blaming H1N1, but could a different strain of Influenza be the cause of Mexican deaths?

LACHEN, Switzerland, May 1 /PRNewswire/ --

- Company Working With Authorities to Ensure Adequate Supply of Virally Inactivated Plasma Derivatives

The impending influenza pandemic will have implications for global stocks of life-saving blood and blood products, warns Swiss-based global biopharmaceutical company, Octapharma.

But it has reiterated the safety of its plasma derivatives and is working closely with health authorities and plasma suppliers to maintain the safety profile and continuous supply of its lifesaving products.

LONDON, May 1 /PRNewswire/ -- Chevron Europe, Eurasia and Middle East, an affiliate of Chevron Corporation, today announced that it has successfully bid for the exploration rights in nine blocks awarded in the 20th Norwegian Licensing Round.

The blocks are located in the Outer Voring Basin in the Norwegian Sea, approximately 155 miles (250 kilometers) west of the coast of Kristiansund, in 3000 feet (1000 meters) of water. Chevron has been appointed as the operator with a 40% percent equity interest in the blocks 6703/7, 8, 9, 10, 11 12 and 6704/7, 8 10. The other participants in the blocks are StatoilHydro with 20 percent equity interest, Shell with 20 percent equity interest and SD0E with 20 percent equity interest.